المؤلفون: Merseburger, Axel Stuart, Chi, Kim N., Chowdhury, Simon, Bjartell, Anders, Chung, Byung Ha, de Santana Gomes, Andrea Juliana Pereira, Given, Robert, Soto, Alvaro Juarez, ÖZGÜROĞLU, Mustafa, Uemura, Hirotsugu, Ye Dingwei, Ye Dingwei, Triantos, Spyros, Mundle, Suneel, McCarthy, Sharon Anne, Larsen, Julie S., Sun Weili, Sun Weili, Bevans, Katherine, Zhang Ke, Zhang Ke, Bandyopadhyay, Nibedita, Agarwal, Neeraj

المساهمون: BC Canc ,, 2615883

مصطلحات موضوعية: Dahili Tıp Bilimleri, ONKOLOJİ, Klinik Tıp, Klinik Tıp (MED), Tıp, Sağlık Bilimleri, İç Hastalıkları, Onkoloji, Oncology, Health Sciences

Relation: JOURNAL OF CLINICAL ONCOLOGY; Chi K. N. , Chowdhury S., Bjartell A., Chung B. H. , de Santana Gomes A. J. P. , Given R., Soto A. J. , Merseburger A. S. , ÖZGÜROĞLU M., Uemura H., et al., "Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).", JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.6, 2021; av_0ab8c804-54bf-4dce-904a-54e66d6442bd; vv_1032021; http://hdl.handle.net/20.500.12627/168206; https://doi.org/10.1200/jco.2021.39.6_suppl.11; 39

الاتاحة: https://hdl.handle.net/20.500.12627/168206
https://doi.org/10.1200/jco.2021.39.6_suppl.11